期刊文献+

降钙素原对短程抗菌药物治疗老年缺血性卒中相关性肺炎的指导价值 被引量:2

Value of serum procalcitonin guidance on short-duration antibiotic therapy in elderly patients with ischemic stroke complicated with stroke-associated pneumonia
原文传递
导出
摘要 目的探讨监测血清降钙素原(PCT)水平对短程抗菌药物治疗老年缺血性卒中相关性肺炎(SAP)的指导价值。方法 125例符合标准的老年缺血性卒中后SAP患者随机分为常规抗菌药物治疗组(常规组)和短程抗菌药物治疗组(短程组)。常规组62例患者由经治医生按照我国抗菌药物使用指南进行抗菌药物治疗并决定抗菌药物疗程;短程组63例患者在使用抗菌药物5 d后,进行连续PCT监测,在血清PCT〈0.25μg/L并且体温正常时,停用抗菌药物,否则继续使用抗菌药物至体温正常后停用抗菌药物。观察2组患者的住院时间、抗菌药物疗程、临床有效率以及治疗后28 d病死率、美国国立卫生研究院卒中量表(NIHSS)评分和Barthel指数。出院后继续随访6月,采用Kaplan-Meier生存曲线比较2组患者生存率。结果短程组与常规组患者在临床有效率、治疗后28 d病死率、NIHSS评分和Barthel指数方面比较,差异无统计学意义(P均〉0.05)。短程组的住院时间[(11.9±3.1)d]和抗菌药物疗程[(7.3±1.5)d]均短于常规组[分别为(14.2±5.2)d和(10.2±2.5)d,P均〈0.05]。6月随访期结束时共有7例死亡,死亡率为6.0%,其中常规组死亡3例,短程组死亡4例。Kaplan-Meier分析表明,2组患者6月生存率差异无统计学意义(χ^2=0.150,P=0.699)。结论监测PCT水平用于指导老年SAP的短程抗菌药物疗法是安全的,能够缩短患者抗菌药物疗程和住院时间。 Objective To evaluate the value of serum procalcitonin( PCT) guidance on short-duration antibiotic therapy in elderly patients with ischemic stroke complicated with stroke-associated pneumonia( SAP). Methods 125 eligible elderly patients with ischemic stroke with SAP were randomly assigned into two groups: standard antibiotic therapy group( standard group,n = 62) and short-duration antibiotic group( short-duration group,n = 63).Standard group received antibiotics according to the physician's advice and short-duration group was treated with antibiotics according to serum PCT level. If PCT 0. 25 μg / L and patients had no fever,antibiotic would be stopped. Length of hospitalization,duration of antibiotics,clinical efficacy,mortality,NIHSS and Barthel index on the 28 th day were observed and compared between two groups. A Kaplan-Meier survive curve was constructed to assess the 6-month survival. Results Clinical efficacy,mortality,NIHSS and Barthel index on the 28 th day were similar in two groups( P〈0. 05). The length of hospitalization[( 11. 9±3. 1) d]and antibiotic duration [( 7. 3±1. 5) d]in short-duration group were shorter than those of standard group[( 14. 2±5. 2) d and( 10. 2±2. 5) d,P〈0. 05]. The Kaplan-Meier survival curve showed that 6-month mortality rate was similar in two groups( χ^2= 0. 150,P = 0. 699). Conclusions Monitoring PCT is safe to guide short-duration antibiotic therapy in elderly patients with ischemic stroke complicated with SAP,and antibiotic duration and length of hospitalization can be reduced.
出处 《实用老年医学》 CAS 2016年第6期500-502,共3页 Practical Geriatrics
基金 上海交通大学附属第六人民医院人才培养基金(2013025)
关键词 降钙素原 老年人 缺血性卒中 卒中相关性肺炎 procalcitonin aged ischemic stroke stroke-associated pneumonia
  • 相关文献

参考文献8

  • 1Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke[J]. Neurology, 2011, 77(14):1338-1345.
  • 2赵旭,吴菊芳,修清玉,王辰,张德平,黄建安,谢灿茂,孙圣华,吕晓菊,司斌,肖组克,张婴元.左氧氟沙星750mg注射液5日短程疗法治疗社区获得性肺炎的多中心临床研究[J].中国感染与化疗杂志,2014,14(6):493-502. 被引量:15
  • 3何礼贤.如何确定肺炎患者的短程抗菌治疗[J].中华结核和呼吸杂志,2015,38(1):2-4. 被引量:2
  • 4Rowland T, Hilliard H, Barlow G. Procalcitonin: potential role in diagnosis and management of sepsis [ J ]. Adv Clin Chem, 2015, 68(1) :71-86.
  • 5Lindstrom ST, Wong EK. Procalcitonin, a valuable biomarker assisting clinical decision-making in the manage- ment of community-acquired pneumonia [ J ]. Intern Med J, 2014, 44(4) :390-397.
  • 6董宏艳,刘先华,周智勇,赵艳萍,王敏,黄妍,郝栋慧,田璠,王宏,曾源.降钙素原和APACH Ⅱ评分对老年脓毒症患者病情判断及预后评估的研究[J].实用老年医学,2015,29(6):457-460. 被引量:27
  • 7Lee M, Snyder A. The role of procalcitonin in community- acquired pneumonia: a literature review [ J ]. Adv Emerg Nurs J, 2012, 34(3) :259-271.
  • 8Horie M, Ugajin M, Suzuki M, et al. Diagnostic and prog- nostic value of procalcitonin in community-acquired pneumonia [ J ]. Am J Med Sci, 2012, 343 ( 1 ) : 30-35.

二级参考文献50

  • 1黄海辉,张婴元,任振义,郑红光,俞云松,吕晓菊,肖祖克,杨惠芬,修清玉,陈宝元,岳红梅,郝青林,黄健安,马惠,肖伟,郭东阳,司彬,孙圣华,张伟,李其皓,沈华浩,段建,李华茵,姚婉贞,顾俊明,夏前明,应可净,刘翱,杨和平,施敏骅,孙铁英,丁国华,吴国明.左氧氟沙星500mg片日1次治疗下呼吸道感染和泌尿道感染的非对照、开放、多中心临床研究[J].中国感染与化疗杂志,2010,10(4):248-257. 被引量:23
  • 2王泽宇,吴允孚.C反应蛋白检测在治疗呼吸机相关性肺炎中的作用[J].实用老年医学,2013,27(1):38-40. 被引量:22
  • 3成人严重感染与感染性休克血流动力学监测与支持指南[J].中华急诊医学杂志,2007,16(2):121-126. 被引量:69
  • 4陈灏珠.实用内科学[M]12版.北京:人民卫生出版社,2005.1746-1750.
  • 5Guthrie R. Community-acquired lower respiratory tract infections: etiology and treatment[J], Chest, 2001,120(6) : 2021-2034.
  • 6Huang HH, Zhang YY, Xiu QY, et al. Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients[J]. Eur J Clin Microbiol Infect Dis, 2006,25 (6) : 369-374.
  • 7Sahm DF, Brown NP, Draghi DC, et al. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001 2005 [J]. Postgrad Med, 2008,120(3 Suppl 1):8-15.
  • 8Thornsberry C, Brown NP, Draghi DC, et al. Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005[J]. Postgrad Med, 2008,120(3 Suppl 1):32-38.
  • 9Frank E, Liu J, Kinasewitz G, et al. A multicenter, open- label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia[J]. Clin Ther, 2002,24(8) : 1292-1308.
  • 10Dunbar LM, Wunderink RG, Habib MF, et al. Hign-ciose, short-course levofloxaein for community-acquired pneumonia: a new treatment paradigm[J]. Clin Infect Dis, 2003,37(6); 752-760.

共引文献40

同被引文献22

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部